FREMONT, Calif. (Diya TV) — In a groundbreaking development, Neuralink showcased its first human patient, Noland Arbaugh, using their brain implant to control a computer cursor while playing chess. Arbaugh, a 29-year-old quadriplegic who lost mobility in a diving accident eight years ago, became the inaugural recipient of the Neuralink device as part of the company’s human trial.

The live demonstration, streamed on X platform, revealed Arbaugh maneuvering the cursor on a laptop screen solely through his thoughts. Describing the experience, he likened it to “using the Force on the cursor,” expressing gratitude for the transformative impact on his life.

Arbaugh’s procedure, conducted in January, marks a significant milestone for Neuralink, founded by Elon Musk, with aspirations to develop brain-computer interfaces (BCIs) enabling paralyzed individuals to control computers with their minds. The implanted device, dubbed “Telepathy” by Musk, aims to restore autonomy to those with unmet medical needs.

While Arbaugh’s demonstration signals progress, it also underscores the challenges ahead. He acknowledged that the technology is not flawless, emphasizing the ongoing journey of refinement and improvement. However, Arbaugh emphasized that even in its current state, the implant has already enhanced his quality of life.

Neuralink’s initiative joins a competitive landscape of neurotechnology startups, including Blackrock Neurotech and Synchron, each pursuing unique approaches to BCI development. Despite Neuralink’s high-profile status, questions remain about the scope and impact of its endeavors, with scrutiny from medical ethicists regarding the transparency of its claims.

The release of the video comes amid ongoing scrutiny of Neuralink’s procedures and devices. Earlier inspections by the U.S. Food and Drug Administration revealed concerns about record-keeping and quality controls for animal experiments. However, Neuralink remains focused on advancing its mission to unlock human potential through neural interfaces.

While Neuralink’s journey is still in its early stages, the company’s commitment to innovation offers hope for individuals with neurological conditions.